Reishi, Lingzhi · 2024 · Journal Article
High relevanceEffects of Ganoderma Lucidum supplementation on the growth performance, biochemical blood parameters, antioxidant and immunity status, and meat quality in slow-growing broilers
Ganoderma lucidum
Key points
- A total of 216 one-day-old broiler chickens were randomly assigned to 3 treatment groups: a basal control diet with 0 mg/kg (G. lucidum), 300 mg/kg (G. lucidum), and 600 mg/kg (G. lucidum) for 50 d
- The findings showed that G. lucidum showed an insignificant improvement in body weight and average body weight gain (P = 0.06 (during the early fattening period, and reduced the mortality rate (P < 0.001)
- G. lucidum treatments increased plasma levels of superoxide dismutase activity (T-SOD) and interferon gamma (IFN-γ) at 21 d of age and decreased plasma activity of aspartate aminotransferase (AST) at 50 d of age
- Compared to the control group, the levels of plasma urea nitrogen (UN) and inducible nitric oxide synthase (iNOS) decreased (P < 0.05) at a low dose of 300 mg G. lucidum/kg and interleukin 6 (IL-6) increased at a high dose of 600 mg G. lucidum/kg at 21 d of age
- Plasma immunoglobulin A (IgA) levels increased (P < 0.05) at a high dose of 600 mg G. lucidum/kg, while malondialdehyde (MDA) decreased at a low dose of 300 mg G. lucidum/kg at 50 d of age
- A significant increase (P < 0.05) in succinate dehydrogenase (SDH) activity in the liver was observed in birds fed 600 mg G. lucidum/kg
From the paper
Abstract
Ganoderma Lucidum (G. lucidum) is an edible mushroom and it has been used as a medicinal fungus for centuries. We evaluated the efficacy of G. lucidum on the growth performance, biochemical blood parameters, antioxidant and immunity status, and meat quality in slow-growing broilers. A total of 216 one-day-old broiler chickens were randomly assigned to 3 treatment groups: a basal control diet with 0 mg/kg (G. lucidum), 300 mg/kg (G. lucidum), and 600 mg/kg (G. lucidum) for 50 d. The findings showed that G. lucidum showed an insignificant improvement in body weight and average body weight gain (P = 0.06 (during the early fattening period, and reduced the mortality rate (P < 0.001). In addition, dietary G. lucidum imposed changes in plasma indices, in a dose- and age-dependent manner. G. lucidum treatments increased plasma levels of superoxide dismutase activity (T-SOD) and interferon gamma (IFN-γ) at 21 d of age and decreased plasma activity of aspartate aminotransferase (AST) at 50 d of age. Compared to the control group, the levels of plasma urea nitrogen (UN) and inducible nitric oxide synthase (iNOS) decreased (P < 0.05) at a low dose of 300 mg G. lucidum/kg and interleukin 6 (IL-6) increased at a high dose of 600 mg G. lucidum/kg at 21 d of age. Plasma immunoglobulin A (IgA) levels increased (P < 0.05) at a high dose of 600 mg G. lucidum/kg, while malondialdehyde (MDA) decreased at a low dose of 300 mg G. lucidum/kg at 50 d of age. A significant increase (P < 0.05) in succinate dehydrogenase (SDH) activity in the liver was observed in birds fed 600 mg G. lucidum/kg. G. lucidum treatments increased (P = 0.003) mRNA expressions of jejunal B-cell lymphoma/leukemia-2 (Bcl-2). No differences were observed in the physicochemical indices of meat, except for redness (a*), which was lower (P = 0.02) in birds fed G. lucidum at a high dose of 600 mg/kg compared to the control diet. The findings suggest that G. lucidum would be considered as a feed supplement inclusion with possible ameliorative changes on broilers health status.
Citation
Wang J, Azzam MM, Xiong T, Wang Y, Ye J, Fan Q, et al. (2024). Effects of Ganoderma Lucidum supplementation on the growth performance, biochemical blood parameters, antioxidant and immunity status, and meat quality in slow-growing broilers. Journal of applied poultry research
Open citation